ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer and Shionogi as shareholders, today announced positive findings from the company's EMBRACE phase IIb study.1 The ...
Zacks Investment Research on MSN1d
Ionis Out-Licenses Rights for Rare Blood Cancer Drug to OnoIonis Pharmaceuticals IONS signed a license agreement with Japan-based Ono Pharmaceutical. Per the terms, Ono has acquired ...
French FM Jean-Noel Barrot Says No Such Thing as Global South; G20 Foreign Ministers’ Meeting Ongoing in South Africa The Group of 20 foreign ministers’ meeting is being held in South Africa from Feb.
Amongst the APEC countries and regions in the survey, hospitalisation costs per older adult in Singapore amounted to SGD ...
An international collaboration of researchers, sponsored by GSK and working on behalf of the ANCHOR-1 and ANCHOR-2 trial ...
Want to relive that Japanese holiday, or get your eye in before you head overseas? You're in luck, because Melbourne is full of top-tier Japanese restaurants. Whether you’re craving sushi, ramen, ...
In this article, we are going to take a look at where GSK plc (NYSE:GSK) stands against the other best vaccine stocks to buy now. On February 24, CNBC reported that President Trump declared that ...
Whether you are an expatriate working in Tokyo, a student pursuing your dream career in Kyoto, or someone who fell in love with Japan, renewing your visa is crucial. In this article, we guide you ...
Bernstein analyst Florent Cespedes maintained a Buy rating on GlaxoSmithKline (GSK – Research Report) today and set a price target of £22.90. The company’s shares opened today at p1,443. ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback